Oxolamine citrate salt
CAS : 1949-20-8
Ref. 3D-BAA94920
2g | 136,00 € | ||
5g | 172,00 € | ||
10g | 248,00 € | ||
25g | 363,00 € | ||
50g | 518,00 € |
Informations sur le produit
- 1,2,4-Oxadiazole, 5-[2-(diethylamino)ethyl]-3-phenyl-, citrate (1:1)
- 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- 3-Phenyl-5-(diethylaminoethyl)-1,2,4-oxadiazole citrate
- 5-(Diethylaminoethyl)-3-phenyl-1,2,4-oxadiazole citrate
- 5-[2-(Diethylamino)Ethyl]-3-Phenyl-1,2,4-Oxadiazole Citrate Salt
- Af 438
- Bredon
- Broncatar
- Flogobron
- N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanaminium 3,4-dicarboxy-3-hydroxybutanoate
- Voir d'autres synonymes
- NSC 100298
- Oxarmin
- Oxolamine Dihydrogen Citrate
- Perebron
- Prilon
- Skf 9976
Oxolamine citrate salt is a pharmaceutical drug used for the treatment of scleroderma. It acts as an iron chelator and inhibits the production of the cytotoxic agent, podophyllotoxin, by inhibiting its conversion to epipodophyllotoxin. Oxolamine citrate salt has been shown to have a beneficial effect on Alzheimer's disease and may have therapeutic potential in other neurological diseases such as Parkinson's disease. The compound has been shown to inhibit acetonitrile-induced hyperactivity in mice. Oxolamine citrate salt has also been found to be effective against Pseudomonas aeruginosa and Staphylococcus aureus isolates that are resistant to oxacillin, ginkgetin, or pseudoephedrine. This drug can be analyzed using liquid chromatography with an acetonitrile gradient and a hypersil C18 column.
Propriétés chimiques
Question d’ordre technique sur : 3D-BAA94920 Oxolamine citrate salt
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages